Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5204843 | 0.94 | GABRP (0.31) | — | |
| SCHEMBL6856449 | 0.85 | HTR2C (0.38) | HTR2CHTR2BKDM4ESLC6A4SLC6A2 | |
| SCHEMBL5207532 | 0.83 | HTR2C (0.30) | HTR2CHTR2B | |
| SCHEMBL5212503 | 0.82 | GABRP (0.37) | — | |
| SCHEMBL6862816 | 0.80 | SLC18A3 (0.34) | KDM4EKDM1A | |
| SCHEMBL6863280 | 0.80 | SLC6A4 (0.32) | HTR2CHTR2BKDM4ESLC6A4SLC6A2 | |
| SCHEMBL6864202 | 0.78 | KDM1A (0.36) | KDM4EKDM1ACYP2D6 | |
| SCHEMBL6864599 | 0.78 | MMP9 (0.47) | KDM1AKCNH2 | |
| SCHEMBL5209800 | 0.78 | — | — | |
| SCHEMBL6860926 | 0.76 | THRB (0.36) | HTR2CHTR2BKDM4ESLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6794471-B2 | OF A HYDROXYHYDROCARBYL- OR MERCAPTOHYDROCARBYL- DITHIOLANE; CURED OPTICAL ARTICLE FORMED BY PHOTOPOLYMERIZING THE ACRYLATE | MITSUI CHEMICALS, INC. (JP) | 2004-09-21 | — | — | US | disclosed |
| EP-1193264-B1 | Acrylic ester compound and usage thereof | MITSUI CHEMICALS INC (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20020061995-A1 | Acrylic ester compound and usage thereof | MITSUI CHEMICALS, INC. (JP) | 2002-05-23 | — | — | US | disclosed |
| EP-1193264-A1 | Acrylic ester compound and usage thereof | Mitsui Chemicals, Inc. (JP) | 2002-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061995-A1 | Acrylic ester compound and usage thereof | ASS1, HAT1, EIF2B1 | HTR2C 2925/4885HTR2B 2355/4885KDM4E 743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.